At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Effectiveness of Advanced Hybrid Closed-loop Systems (AHCL) for Achieving Time in Tight Range (TiTR) of Interstitial Glucose Among Adult Type 1 Diabetes (T1D) Patients
In Brief
An observational study evaluating MM780G, TTSX2, and 1 other intervention for Type 1 Diabetes (T1D). Completed, enrolled 189 participants across 3 sites.
Detailed Summary
Diabetes is a chronic disease with a relevant public health burden. Maintaining blood glucose levels as close to normal as possible is essential to avoid the associated microvascular and macrovascular complications. Therefore, the key to prevent and/or reduce the development of these chronic complications lies in an adequate and strict glycemic control. This study consist of a cross-sectional observational study among adult patients with type 1 diabetes (T1D). The main objective is to analyze the effect on time in tight range (TiTR, 70-140 mg/dL) of interstitial glucose between three different advanced hybrid closed-loop (AHCL) systems.
Study Details
Timeline
Interventions
SmartGuard in Medtronic Minimed 780G advaced hybrid closed-loop
Control-IQ in Tandem T Slim X2 advanced hybrid closed-loop
CamAPS Fx in Ypsopump advanced hybrid closed-loop